1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Bulgaria Pharmaceuticals and Healthcare Report Q3 2016

Bulgaria Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates

BMI View: The vote of no confidence against Bulgaria's government, despite being unsuccessful, hashighlighted the dissatisfaction of a large proportion of the population with proposed healthcare reforms. Anumber of recent controversies have lowered the public's opinion of its governance, but new legislationappears to be addressing the long-held issue of an over-reliance on private spending. Cost-containment willaffect revenue-generating opportunities for drugmakers, but generic medicines will gain market share.

Headline Expenditure Projections

- Pharmaceuticals: BGN2.71bn (USD1.54bn) in 2015 to BGN2.89bn (USD1.58bn) in 2016; +6.6% inlocal currency terms and +2.5% in US dollar terms. Forecast revised slightly downwards compared to theprevious quarter.

- Healthcare: BGN7.45bn (USD4.22bn) in 2015 to BGN7.85bn (USD4.28bn) in 2016; +5.4% in localcurrency terms and +1.5% in US dollar terms. Forecast increased compared to the previous quarter.

Table Of Contents

Bulgaria Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Bulgaria 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bulgaria 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Bulgaria 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Bulgaria 2014-2020) 28
Industry Risk/Reward Index 29
Central And Eastern Europe Risk/Reward Index - Q3 2016 29
Bulgaria Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 39
Pricing Regime 40
Reimbursement Regime 43
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Bulgaria 2010-2015) 48
Table: Healthcare Resources (Bulgaria 2010-2015) 48
Table: Healthcare Personnel (Bulgaria 2010-2015) 49
Table: Healthcare Activity (Bulgaria 2010-2015) 49
Table: NHIF Budget, 2014 53
Table: Bulgarian National Health Insurance Fund Revenues (BGN 000s), 2015 53
Research and Development 54
Table: Members Of ARPharM, 2014 54
Clinical Trials 55
Table: Cancer Incidence Rates, 2012-2035 58
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 60
Generic Drugmakers 61
Pharmaceutical Retail Sector 61
Table: Pharmaceutical Wholesale And Retail Market, 2009-2012 63
Company Profile 64
Sopharma 64
Demographic Forecast 68
Demographic Outlook 68
Table: Population Headline Indicators (Bulgaria 1990-2025) 69
Table: Key Population Ratios (Bulgaria 1990-2025) 69
Table: Urban/Rural Population and Life Expectancy (Bulgaria 1990-2025) 70
Table: Population By Age Group (Bulgaria 1990-2025) 70
Table: Population By Age Group % (Bulgaria 1990-2025) 71
Glossary 73
Methodology 75
Pharmaceutical Expenditure Forecast Model 75
Healthcare Expenditure Forecast Model 75
Notes On Methodology 76
Risk/Reward Index Methodology 77
Index Overview 78
Table: Pharmaceutical Risk/Reward Index Indicators 78
Indicator Weightings 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Drug Discovery Outsourcing Global Market  – Forecast To 2022

Drug Discovery Outsourcing Global Market – Forecast To 2022

  • $ 15 000
  • Industry report
  • January 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards ...

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

  • $ 6 995
  • Industry report
  • February 2016
  • by GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes Summary The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 ...

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 750
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices. In depth market scenario includes; - Current market size estimates, including domestic market, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.